Our findings showed that a third of patients treated with PD‐1/PD‐L1 immune checkpoint inhibitors were hospitalized for infection and that the rate of hospitalization for infection was nearly three times higher if initiation of treatment with a high‐dose corticosteroid occurred. Here, PDCD1 is linked to infection.